Aristeia Capital’s Vicarious Surgical RBOT Stock Holding History

Aristeia Capital’s Portfolio RBOT Stock Details RBOT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-1,086	Closed	-$346K	–	732
2021 Q4	$346K	Buy	+1,086	New	+$383K	0.01%	480
2021 Q2	–	Sell	-33,973	Closed	-$10.1M	–	508
2021 Q1	$10.1M	Buy	+33,973	New	+$10.4M	0.2%	162

Other funds holding RBOT

VK Services Menlo Park, California $543K AUM 174.84% 1-Year Est. Return

AMH

Aspex Management (HK) Central, Hong Kong $6.9B AUM 28.37% 1-Year Est. Return

CFM

Comprehensive Financial Management Los Gatos, California $3.01B AUM 2.93% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

VIA

Vident Investment Advisory Alpharetta, Georgia $2.9B AUM 24.67% 1-Year Est. Return

DDD Partners Bellevue, Washington $1.45B AUM 9.14% 1-Year Est. Return

Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

MAM

Maytree Asset Management Hong Kong $141M AUM 114% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Aristeia Capital's RBOT Position: Q1 2022 in Review

Aristeia Capital sold out of Vicarious Surgical (RBOT) in Q1 2022, closing a stake of 1,086 shares — an estimated $346K sold.

Aristeia Capital first reported a position in RBOT in Q1 2021 and held it in 2 quarters. The position peaked at $10.1M in Q1 2021. 61 funds tracked by Wall St. Rank hold RBOT as of Q1 2022.

Aristeia Capital reported no remaining Vicarious Surgical position as of Q1 2022 after selling out during the quarter.
Aristeia Capital sold 1,086 Vicarious Surgical shares in Q1 2022, an estimated $346K.
Aristeia Capital first reported a position in Vicarious Surgical in Q1 2021 and held it in 2 quarters.
Aristeia Capital's Vicarious Surgical position peaked at $10.1M in Q1 2021.
61 funds tracked by Wall St. Rank held Vicarious Surgical as of Q1 2022.

Based on Aristeia Capital's 13F filing for Q1 2022, filed 16 May 2022.